The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells

Published:2024-09-14 Issue:1 Volume:17 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

Sue Sung-How,Tseng Wei-Cheng,Wu Zih-Syuan,Huang Shih-Ming,Chen Jia-Lin,Wu Zhi-Fu,Lai Hou-Chuan

Funder

Teh-Tzer Study Group for Human Medical Research Foundation

National Science and Technology Council

Kaohsiung Medical University Hospital

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13048-024-01509-x.pdf

Reference60 articles.

1. Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280–304.

2. Gaona-Luviano P, Medina-Gaona LA, Magaña-Pérez K. Epidemiology of ovarian cancer. Chin Clin Oncol. 2020;9(4):47.

3. Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–96.

4. Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240–53.

5. Kim R. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence. J Translational Med. 2018;16(1):8.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3